Company intelligence / Profile preview

Novatrials

Ownership: Private
Development stage: Other

Overview

Novatrials refers to two distinct companies: Novatrials (Israel), a boutique full-service Contract Research Organization (CRO) supporting clinical research across all phases in Israel, and Novatrials (Australia), an advanced Phase I–III clinical trial site/institute providing rapid start-up and cost-effective solutions for global pharma/CRO partners. Neither company develops its own drugs or has its own therapeutic pipeline.

Therapeutic areas: EndocrinologyOtherDermatologyCardiovascularInfectious Diseases
Industry: Contract Research Organization

Beyond the preview

Go deeper on Novatrials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novatrials.

Explore the full profile